Skip to content

Detection of Usability Errors of a Medical Device Zeneo®

Detection of Usability Errors of a Medical Device Zeneo®

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03808246
Enrollment
60
Registered
2019-01-17
Start date
2019-04-24
Completion date
2019-12-09
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

The research addresses the question of the number of participants needed to identify as many usability-induced errors as possible in the context of summative usability tests. The research addresses also the impact of the ecological validity of the test environment on the number of usability-induced errors uncovered.

Detailed description

In order to determine how many participants must be recruited to detect 95% of the anticipated use errors, two groups of participants (naives or informed to the type of device under evaluation) will take part to usability test of a demo version of an auto injector pen in one of two test environments (realistic or laboratory-like). The combination of the 2 types of users and the two types of environment composes 4 arms. By default, 15 participants will be recruited per arm (in conformity with usual guidelines). If, in a given group, 95% of anticipated errors are detected, no more participants will be recruited in the arm. Otherwise, 5 other participants will be recruited till the 95% threshold is reached with a maximum of 40 participants per group.

Interventions

OTHERusing the demo version of a self-injector pen

Participants, whatever the arm they are included in, will have to use the demo version of the auto-injector pen during a simulation of an anaphylactic shock.

Sponsors

University Hospital, Lille
Lead SponsorOTHER
National Research Agency, France
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

2 profiles of participants (naïves vs. informed) x 2 types of test environment (realistic vs. laboratory-like). Each participant, depending on her/his profile is assigned to one "profile of participant" group and randomly to one "type of test environment" group.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Two types of participants (healthy people) will be recruited: participants informed about auto-injector pens (BUT NOT PATIENTS) and participants naïves on this topic. Inclusion Criteria: * Able to use the device * Without previous experience of anaphylactic shock * Not taking a psychotropic drug * Without hearing impairment * Covered by social security * Who signed the consent form and the information letter * Who agree to conform to the procedure of the study -

Exclusion criteria

* Pregnant women * Vulnerable Persons * Persons under administrative supervision * Persons who are subject to a judicial protection measure * Persons who do not understand correctly French.

Design outcomes

Primary

MeasureTime frame
For each arm, number of participants needed to uncover 95% of the use errors knownthrough study completion, an average of 6 months

Secondary

MeasureTime frame
number of use errors uncovered per participantthrough study completion, an average of 6 months
number of participants who detected a given errorthrough study completion, an average of 6 months
number of unanticipated errors detectedthrough study completion, an average of 6 months

Countries

France

Contacts

PRINCIPAL_INVESTIGATORRomaric Marcilly, PhD

University Hospital, Lille

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026